[Irreversible electroporation (IRE) : A minimally invasive therapeutic option in prostate cancer]
- PMID: 28477079
- DOI: 10.1007/s00117-017-0251-x
[Irreversible electroporation (IRE) : A minimally invasive therapeutic option in prostate cancer]
Abstract
Clinical problem: Prostate cancer is one of the most common malignant diseases in older men. As such, screening and early detection are of crucial importance.
Standard treatment: The standard management of prostate cancer includes radical prostatectomy, radiation therapy, or hormonal therapy. These standard therapies yield excellent oncologic results, but also produce significant side effects. In cases of low-risk prostate cancer, these therapies might result in over-treatment; for this reason, active surveillance has been introduced. However, acceptance of this strategy varies between patients.
Treatment innovations: Irreversible electroporation is a novel non-thermal ablation technique for soft tissues. The ablation mechanism of irreversible electroporation has some theoretical advantages in the treatment of prostate cancer. It allows image-guided focal treatment of malignant prostate tissue and a potential sparing of adjacent structures, thereby theoretically resulting in a marked reduction in treatment-related side effects compared with standard management.
Practical recommendations: Although irreversible electroporation is a promising ablation technique, it should only be used in the context of clinical trials to treat prostate cancer due to the current lack of solid evidence for this new technology.
Keywords: Ablation; Active surveillance; Image-guided; Radiology; Side-effects profile.
Similar articles
-
The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.BMJ Open. 2014 Oct 29;4(10):e006382. doi: 10.1136/bmjopen-2014-006382. BMJ Open. 2014. PMID: 25354827 Free PMC article.
-
Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.BMC Cancer. 2016 May 5;16:299. doi: 10.1186/s12885-016-2332-z. BMC Cancer. 2016. PMID: 27150293 Free PMC article. Clinical Trial.
-
Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.World J Urol. 2017 Jan;35(1):11-20. doi: 10.1007/s00345-016-1838-y. Epub 2016 May 4. World J Urol. 2017. PMID: 27147512 Review.
-
MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.Eur Radiol. 2016 Jul;26(7):2252-60. doi: 10.1007/s00330-015-4042-3. Epub 2015 Oct 8. Eur Radiol. 2016. PMID: 26449559 Free PMC article. Clinical Trial.
-
Focal Therapy of Prostate Cancer Using Irreversible Electroporation.Tech Vasc Interv Radiol. 2015 Sep;18(3):147-52. doi: 10.1053/j.tvir.2015.06.005. Epub 2015 Jun 18. Tech Vasc Interv Radiol. 2015. PMID: 26365544 Review.
Cited by
-
Electrochemotherapy as a New Modality in Interventional Oncology: A Review.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818785329. doi: 10.1177/1533033818785329. Technol Cancer Res Treat. 2018. PMID: 29986632 Free PMC article. Review.
-
Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America.Vaccines (Basel). 2020 Sep 17;8(3):537. doi: 10.3390/vaccines8030537. Vaccines (Basel). 2020. PMID: 32957424 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials